ID

41151

Description

Stereotactic Body Radiotherapy for Unresectable Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01910909

Link

https://clinicaltrials.gov/show/NCT01910909

Keywords

Versions (1)
  1. 7/2/20 7/2/20 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

July 2, 2020

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Localized Non-Resectable Adult Hepatocellular Carcinoma NCT01910909

English

Eligibility Localized Non-Resectable Adult Hepatocellular Carcinoma NCT01910909

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients must have a diagnosis of hcc by at least one criterion listed below (klcsg guideline 2009) 1.1 pathologically (histologically or cytologically) proven diagnosis of hcc 1.2 liver nodule in high risk group 1.2.1 if alpha feto protein (afp)≥200 ng/ml , ≥ 1 typical hcc enhancing pattern on dynamic contrast enhanced ct or mri 1.2.2 if afp<200 ng/ml, ≥2 typical hcc enhancing pattern on dynamic contrast enhanced ct, mri, and angiography 1.3 ≥ 2 cm nodule in liver cirrhosis (lc), ≥ 1 typical hcc enhancing pattern on dynamic contrast enhanced ct or mri
Description

Liver carcinoma | Nodule of liver High risk | Alpha one fetoprotein measurement | Liver carcinoma pattern CT with Contrast | Liver carcinoma pattern MRI with contrast | Liver carcinoma pattern Angiography | Nodule size Liver Cirrhosis

Data type

boolean

Alias
UMLS CUI [1]
C2239176
UMLS CUI [2,1]
C0745761
UMLS CUI [2,2]
C4319571
UMLS CUI [3]
C0201539
UMLS CUI [4,1]
C2239176
UMLS CUI [4,2]
C0439712
UMLS CUI [4,3]
C0742919
UMLS CUI [5,1]
C2239176
UMLS CUI [5,2]
C0439712
UMLS CUI [5,3]
C0202671
UMLS CUI [6,1]
C2239176
UMLS CUI [6,2]
C0439712
UMLS CUI [6,3]
C0002978
UMLS CUI [7,1]
C0449457
UMLS CUI [7,2]
C0023890
2. eastern cooperative oncology group performance status 0 or 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
3. size of the hcc ≤ 3 cm or less
Description

Liver carcinoma Size

Data type

boolean

Alias
UMLS CUI [1,1]
C2239176
UMLS CUI [1,2]
C0456389
4. age ≥ 20
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
5. unsuitable for resection or transplant or rfa
Description

Patients Inappropriate Excision | Patients Inappropriate Transplantation | Patients Inappropriate Radiofrequency Ablation

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0728940
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C1548788
UMLS CUI [2,3]
C0040732
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C0850292
6. unsuitable for or refractory to tace or drug eluting beads (deb)
Description

Patients Inappropriate Transarterial Chemoembolization | Unresponsive to Transarterial Chemoembolization | Patients Inappropriate Drug-eluting Embolic Bead

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C3539919
UMLS CUI [2,1]
C0205269
UMLS CUI [2,2]
C3539919
UMLS CUI [3,1]
C0030705
UMLS CUI [3,2]
C1548788
UMLS CUI [3,3]
C3273294
7. agreement of study-specific informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
8. assessment by radiation oncologist and medical oncologist or hepatologist within 28 days prior to study entry?
Description

Assessment Radiation Oncologist | Assessment Oncologist | Assessment Hepatologist

Data type

boolean

Alias
UMLS CUI [1,1]
C1516048
UMLS CUI [1,2]
C1514693
UMLS CUI [2,1]
C1516048
UMLS CUI [2,2]
C0259990
UMLS CUI [3,1]
C1516048
UMLS CUI [3,2]
C4280018
9. child-pugh score a within 14 days prior to study entry
Description

Child-Pugh Clinical Classification

Data type

boolean

Alias
UMLS CUI [1]
C4050412
10. normal liver (liver minus gross tumor volume) ≥ 700 cc
Description

Liver normal Volume

Data type

boolean

Alias
UMLS CUI [1,1]
C0577059
UMLS CUI [1,2]
C0449468
11. target is only one viable hepatocellular carcinoma
Description

Target Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C1521840
UMLS CUI [1,2]
C2239176
12. blood work requirements
Description

Hematologic Test Required

Data type

boolean

Alias
UMLS CUI [1,1]
C0018941
UMLS CUI [1,2]
C1514873
absolute neutrophil count (anc) ≥ 1,500 /mm3, platelet ≥ 70,000/mm3, hgb ≥ 8 g/dl
Description

Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0518015
liver function test (lft): t. bilirubin<3.0 mg/dl, international normalized ratio (inr) < 1.7, albumin ≥ 2.8g/dl, aspartate aminotransferase (ast)/alanine aminotransferase (alt)< 6 x normal
Description

Liver Function Tests | Serum total bilirubin measurement | International Normalized Ratio | Albumin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0023901
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0525032
UMLS CUI [4]
C0201838
UMLS CUI [5]
C0201899
UMLS CUI [6]
C0201836
serum creatinine < 1.5 x normal, or creatinine clearance rate ≥ 60 ml/min
Description

Creatinine measurement, serum | Creatinine clearance measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
13. male, consent contraception at least 6 months childbearing potential woman, consent contraception at least 6 months
Description

Gender Contraceptive methods | Childbearing Potential Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
14. life expectancy more than 12 weeks
Description

Life Expectancy

Data type

boolean

Alias
UMLS CUI [1]
C0023671
15. stable breathing more than 10 minutes
Description

Breathing Stable Duration

Data type

boolean

Alias
UMLS CUI [1,1]
C0004048
UMLS CUI [1,2]
C0205360
UMLS CUI [1,3]
C0449238
16. consent to fiducial marker insertion ( if needed )
Description

Fiducial marker placement

Data type

boolean

Alias
UMLS CUI [1]
C3888577
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. extrahepatic metastasis or malignant nodes
Description

Neoplasm Metastasis Extrahepatic | Lymph nodes Malignant Extrahepatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1517058
UMLS CUI [2,1]
C0024204
UMLS CUI [2,2]
C0205282
UMLS CUI [2,3]
C1517058
2. pregnant and/or breastfeeding woman
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
3. macroscopic vascular tumor involvement
Description

Vascular Neoplasm macroscopic Involvement

Data type

boolean

Alias
UMLS CUI [1,1]
C0027668
UMLS CUI [1,2]
C0439806
UMLS CUI [1,3]
C1314939
4. previous upper abdominal rt history
Description

Therapeutic radiology procedure Upper abdomen

Data type

boolean

Alias
UMLS CUI [1,1]
C1522449
UMLS CUI [1,2]
C0230165
5. uncontrolled active co-morbidity
Description

Comorbidity Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
Back to the top of the page

Similar models

Eligibility Localized Non-Resectable Adult Hepatocellular Carcinoma NCT01910909

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Liver carcinoma | Nodule of liver High risk | Alpha one fetoprotein measurement | Liver carcinoma pattern CT with Contrast | Liver carcinoma pattern MRI with contrast | Liver carcinoma pattern Angiography | Nodule size Liver Cirrhosis
Item
1. patients must have a diagnosis of hcc by at least one criterion listed below (klcsg guideline 2009) 1.1 pathologically (histologically or cytologically) proven diagnosis of hcc 1.2 liver nodule in high risk group 1.2.1 if alpha feto protein (afp)≥200 ng/ml , ≥ 1 typical hcc enhancing pattern on dynamic contrast enhanced ct or mri 1.2.2 if afp<200 ng/ml, ≥2 typical hcc enhancing pattern on dynamic contrast enhanced ct, mri, and angiography 1.3 ≥ 2 cm nodule in liver cirrhosis (lc), ≥ 1 typical hcc enhancing pattern on dynamic contrast enhanced ct or mri
boolean
C2239176 (UMLS CUI [1])
C0745761 (UMLS CUI [2,1])
C4319571 (UMLS CUI [2,2])
C0201539 (UMLS CUI [3])
C2239176 (UMLS CUI [4,1])
C0439712 (UMLS CUI [4,2])
C0742919 (UMLS CUI [4,3])
C2239176 (UMLS CUI [5,1])
C0439712 (UMLS CUI [5,2])
C0202671 (UMLS CUI [5,3])
C2239176 (UMLS CUI [6,1])
C0439712 (UMLS CUI [6,2])
C0002978 (UMLS CUI [6,3])
C0449457 (UMLS CUI [7,1])
C0023890 (UMLS CUI [7,2])
ECOG performance status
Item
2. eastern cooperative oncology group performance status 0 or 1
boolean
C1520224 (UMLS CUI [1])
Liver carcinoma Size
Item
3. size of the hcc ≤ 3 cm or less
boolean
C2239176 (UMLS CUI [1,1])
C0456389 (UMLS CUI [1,2])
Age
Item
4. age ≥ 20
boolean
C0001779 (UMLS CUI [1])
Patients Inappropriate Excision | Patients Inappropriate Transplantation | Patients Inappropriate Radiofrequency Ablation
Item
5. unsuitable for resection or transplant or rfa
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0728940 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C1548788 (UMLS CUI [2,2])
C0040732 (UMLS CUI [2,3])
C0030705 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C0850292 (UMLS CUI [3,3])
Patients Inappropriate Transarterial Chemoembolization | Unresponsive to Transarterial Chemoembolization | Patients Inappropriate Drug-eluting Embolic Bead
Item
6. unsuitable for or refractory to tace or drug eluting beads (deb)
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C3539919 (UMLS CUI [1,3])
C0205269 (UMLS CUI [2,1])
C3539919 (UMLS CUI [2,2])
C0030705 (UMLS CUI [3,1])
C1548788 (UMLS CUI [3,2])
C3273294 (UMLS CUI [3,3])
Informed Consent
Item
7. agreement of study-specific informed consent
boolean
C0021430 (UMLS CUI [1])
Assessment Radiation Oncologist | Assessment Oncologist | Assessment Hepatologist
Item
8. assessment by radiation oncologist and medical oncologist or hepatologist within 28 days prior to study entry?
boolean
C1516048 (UMLS CUI [1,1])
C1514693 (UMLS CUI [1,2])
C1516048 (UMLS CUI [2,1])
C0259990 (UMLS CUI [2,2])
C1516048 (UMLS CUI [3,1])
C4280018 (UMLS CUI [3,2])
Child-Pugh Clinical Classification
Item
9. child-pugh score a within 14 days prior to study entry
boolean
C4050412 (UMLS CUI [1])
Liver normal Volume
Item
10. normal liver (liver minus gross tumor volume) ≥ 700 cc
boolean
C0577059 (UMLS CUI [1,1])
C0449468 (UMLS CUI [1,2])
Target Liver carcinoma
Item
11. target is only one viable hepatocellular carcinoma
boolean
C1521840 (UMLS CUI [1,1])
C2239176 (UMLS CUI [1,2])
Hematologic Test Required
Item
12. blood work requirements
boolean
C0018941 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
absolute neutrophil count (anc) ≥ 1,500 /mm3, platelet ≥ 70,000/mm3, hgb ≥ 8 g/dl
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
Liver Function Tests | Serum total bilirubin measurement | International Normalized Ratio | Albumin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement
Item
liver function test (lft): t. bilirubin<3.0 mg/dl, international normalized ratio (inr) < 1.7, albumin ≥ 2.8g/dl, aspartate aminotransferase (ast)/alanine aminotransferase (alt)< 6 x normal
boolean
C0023901 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0525032 (UMLS CUI [3])
C0201838 (UMLS CUI [4])
C0201899 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
Creatinine measurement, serum | Creatinine clearance measurement
Item
serum creatinine < 1.5 x normal, or creatinine clearance rate ≥ 60 ml/min
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Gender Contraceptive methods | Childbearing Potential Contraceptive methods
Item
13. male, consent contraception at least 6 months childbearing potential woman, consent contraception at least 6 months
boolean
C0079399 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
Life Expectancy
Item
14. life expectancy more than 12 weeks
boolean
C0023671 (UMLS CUI [1])
Breathing Stable Duration
Item
15. stable breathing more than 10 minutes
boolean
C0004048 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Fiducial marker placement
Item
16. consent to fiducial marker insertion ( if needed )
boolean
C3888577 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Neoplasm Metastasis Extrahepatic | Lymph nodes Malignant Extrahepatic
Item
1. extrahepatic metastasis or malignant nodes
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
C0024204 (UMLS CUI [2,1])
C0205282 (UMLS CUI [2,2])
C1517058 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
2. pregnant and/or breastfeeding woman
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Vascular Neoplasm macroscopic Involvement
Item
3. macroscopic vascular tumor involvement
boolean
C0027668 (UMLS CUI [1,1])
C0439806 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
Therapeutic radiology procedure Upper abdomen
Item
4. previous upper abdominal rt history
boolean
C1522449 (UMLS CUI [1,1])
C0230165 (UMLS CUI [1,2])
Comorbidity Uncontrolled
Item
5. uncontrolled active co-morbidity
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial